CIK: 0001012622 · Show all filings
Period: Q2 2017 (← Previous) (Next →)
Filing Date: Aug 14, 2017
Total Value ($000): $632,944 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | TESARO INC | 1,052,579 | $147,214 | 23.3% | $12435.97 | — | COM | 881569107 |
| — | ACCELERATE DIAGNOSTICS INC | 4,719,526 | $129,079 | 20.4% | $27.35 | — | COM | 004304200 |
| — | MAZOR ROBOTICS LTD | 2,471,378 | $85,460 | 13.5% | $11234.47 | — | SPONSORED ADS | 57886P103 |
| — | QUIDEL CORP | 2,527,554 | $68,598 | 10.8% | $25530.00 | — | COM | 74838J101 |
| — | NXSTAGE MEDICAL INC | 2,276,106 | $57,062 | 9.0% | $12876.33 | — | COM | 67072V103 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 8,259,380 | $29,403 | 4.6% | $5.21 | -22.6% | COM | 69404D108 |
| — | AMARIN CORP PLC | 6,424,356 | $25,890 | 4.1% | $680.25 | — | SPONS ADR NEW | 023111206 |
| OPK | OPKO HEALTH INC | 3,636,760 | $23,930 | 3.8% | $7.37 | -4.9% | COM | 68375N103 |
| — | VERMILLION INC | 9,241,956 | $17,005 | 2.7% | $1536.94 | — | COM NEW | 92407M206 |
| — | INTREXON CORP | 689,002 | $16,598 | 2.6% | $4275.17 | — | COM | 46122T102 |
| — | BIOLASE INC | 14,622,050 | $14,183 | 2.2% | $1097.01 | — | COM | 090911108 |
| — | AGENUS INC | 1,597,392 | $6,246 | 1.0% | $3.91 | — | COM | 00847G101 |
| — | EPIZYME INC | 292,380 | $4,415 | 0.7% | $17.15 | — | COM | 29428V104 |
| — | ACCELERATE DIAGNOSTICS INC | 372,900 | $1,974 | 0.3% | $24.20 | — | Call | 00430H102 |
| BIIB | BIOGEN INC | 6,368 | $1,728 | 0.3% | $213.68 | +23.7% | COM | 09062X103 |
| — | CONTRAFECT CORP | 1,182,032 | $1,714 | 0.3% | $5.25 | — | COM | 212326102 |
| — | NXSTAGE MEDICAL INC | 460,800 | $1,469 | 0.2% | $12876.33 | — | Call | 67072V103 |
| — | TESARO INC | 476,400 | $814 | 0.1% | $12435.97 | — | Call | 881569107 |
| — | AQUABOUNTY TECHNOLOGIES INC | 12,204 | $98 | 0.0% | $11.06 | — | COM NEW | 03842K200 |
| — | SECOND SIGHT MED PRODS INC | 50,804 | $64 | 0.0% | $10.26 | — | COM | 81362J100 |